ANG Lifesciences

52.50
-1.17
(-2.18%)
Market Cap (₹ Cr.)
₹70
52 Week High
86.06
Book Value
₹58
52 Week Low
44.49
PE Ratio
PB Ratio
0.98
PE for Sector
38.62
PB for Sector
4.68
ROE
-0.30 %
ROCE
0.35 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-36.06 %
Net Income Growth
-3,768.38 %
Cash Flow Change
-135.97 %
ROE
-4,272.50 %
ROCE
-97.70 %
EBITDA Margin (Avg.)
-32.14 %

Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
32
37
118
88
47
96
72
59
45
41
51
30
17
34
18
Expenses
31
32
89
69
42
84
60
49
43
43
45
28
19
32
18
EBITDA
2
4
29
19
5
13
11
9
2
-2
6
2
-2
2
-1
Operating Profit %
5 %
11 %
25 %
22 %
10 %
13 %
16 %
16 %
5 %
-36 %
11 %
4 %
-10 %
6 %
-12 %
Depreciation
0
1
0
1
1
2
2
2
2
3
2
2
2
2
2
Interest
1
1
1
1
2
4
3
3
3
1
2
2
2
3
2
Profit Before Tax
0
2
28
17
2
7
6
4
-2
-6
2
-2
-6
-3
-4
Tax
0
1
7
4
1
2
2
2
-1
-1
1
-0
-0
0
0
Net Profit
0
2
21
13
1
5
3
3
-2
-5
2
-2
-5
-4
-3
EPS in ₹
0.42
2.74
39.67
12.24
1.24
5.19
3.84
2.19
-1.22
-3.95
1.28
-1.53
-3.51
-2.73
-2.12

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
26
35
47
68
81
94
142
269
253
217
Fixed Assets
9
9
9
9
21
21
22
82
79
53
Current Assets
17
26
38
47
60
73
112
182
168
158
Capital Work in Progress
0
0
0
12
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
4
4
4
Other Assets
17
26
38
47
60
73
120
183
170
161
Total Liabilities
23
31
39
45
52
60
101
185
167
140
Current Liabilities
15
24
34
35
42
51
92
154
146
126
Non Current Liabilities
8
7
5
10
10
9
9
31
21
14
Total Equity
3
5
7
23
29
35
41
83
86
77
Reserve & Surplus
-0
1
4
18
24
29
36
73
72
64
Share Capital
4
4
4
5
5
5
5
10
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
1
-0
1
3
-1
-0
0
-0
-0
Investing Activities
-2
-3
-3
-13
-1
-2
-8
-42
-9
20
Operating Activities
3
2
3
1
7
5
-11
27
26
-13
Financing Activities
-1
2
-0
13
-4
-4
19
15
-17
-7

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
71.01 %
71.07 %
71.09 %
71.14 %
71.15 %
71.15 %
71.15 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
28.99 %
28.93 %
28.91 %
28.86 %
28.85 %
28.85 %
28.85 %
29.40 %
29.40 %
29.40 %
29.40 %
29.40 %
29.40 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,870.55 4,48,231.75 42.51 49,887.17 12.06 9,648 42.62 67.80
1,643.20 1,32,231.02 29.75 26,520.66 14.17 4,155 17.77 55.33
6,691.45 1,10,988.19 19.94 28,905.40 12.36 5,578 -0.90 48.83
2,701.30 1,09,421.92 55.76 10,615.63 19.57 1,942 9.89 70.97
1,063.45 1,05,835.69 25.39 19,831.50 13.82 3,831 30.78 34.48
2,221.10 1,01,003.81 44.63 20,141.50 19.94 1,936 77.69 57.19
1,526.75 88,051.92 24.55 29,559.25 17.55 3,169 61.17 52.73
6,226.65 72,286.01 33.62 12,978.42 9.84 1,811 91.18 59.26
1,689.20 47,904.26 - 12,653.09 6.58 -1,831 96.52 54.81
371.45 45,052.52 28.87 15,621.20 35.25 1,298 478.78 52.54

Corporate Action

Technical Indicators

RSI(14)
Neutral
50.04
ATR(14)
Volatile
3.04
STOCH(9,6)
Neutral
27.28
STOCH RSI(14)
Neutral
31.98
MACD(12,26)
Bearish
-0.22
ADX(14)
Weak Trend
21.45
UO(9)
Bearish
45.46
ROC(12)
Uptrend But Slowing Down
1.21
WillR(14)
Neutral
-63.08